文献速递认知障碍与痴呆帕金森病与运动障碍

路易体痴呆临床特征可在6个月内检测到进展

Progression of Clinical Features in Lewy Body Dementia Can Be Detected Over 6 Months.
PubMed 文献 · Neurology · 2021-08-17

6个月内MMSE下降1.3分、UPDRS-III增加3.2分、DCFS增加1.3分、NPI睡眠增加1.2分,DLB与PDD变化速率无差异。

要点

  • 6个月内可检测到认知、运动、波动和睡眠症状的显著进展。
  • DLB与PDD的核心特征变化速率无差异。
  • 常用临床量表变化率可作为治疗试验的临床终点。

核心结论

  • 路易体痴呆核心临床特征在6个月内可检测并量化显著变化,DLB与PDD变化速率无差异。

主要发现

  • MMSE 6个月下降1.3分(p=0.002)。
  • UPDRS-III 6个月增加3.2分(p=0.018)。
  • DCFS 6个月增加1.3分(p=0.001)。
  • NPI睡眠6个月增加1.2分(p=0.04)。
  • 未检测到神经精神症状的显著变化。

关键数值与推荐

  • MMSE变化1.3分(p=0.002),UPDRS-III变化3.2分(p=0.018),DCFS变化1.3分(p=0.001),NPI睡眠变化1.2分(p=0.04)。

临床怎么用

  • 可用MMSE、UPDRS-III、DCFS和NPI睡眠在6个月内量化路易体痴呆核心特征进展,作为治疗试验终点。

局限性

  • 未检测到神经精神症状显著变化;研究时限为6个月;样本来自随机对照试验人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to quantify the trajectory and magnitude of change of the key clinical features and corresponding symptom domains of dementia with Lewy bodies (DLB) and Parkinson disease dementia (PDD), including global cognition, parkinsonism, recurrent visual hallucinations, cognitive fluctuations, and sleep disturbance. METHODS: One hundred sixteen patients with Lewy body dementia (DLB = 72, PDD = 44) underwent assessment at baseline and 3 and 6 months as part of a prospective multicenter randomized controlled trial. Linear mixed models were constructed for core outcome measures using the Mini-Mental State Examination (MMSE), motor section of the Unified Parkinson's Disease Rating Scale (UPDRS-III), Dementia Cognitive Fluctuations Scale (DCFS), and Neuropsychiatric Inventory (NPI). RESULTS: Within the time frame of our study (6 months), we were able to identify a significant cognitive decline of 1.3 points on the MMSE (p = 0.002) and significant worsening of motor parkinsonism with an increase in UPDRS-III score of 3.2 points (p = 0.018). Fluctuation severity also increased using the DCFS with a 6-month change in score of 1.3 points (p = 0.001). Uniquely, a signal for increased severity of sleep symptoms of 1.2 points (NPI-sleep) was also detectable (p = 0.04). Significant changes in neuropsychiatric symptoms were not detected. There was no difference in rates of change of scores between DLB and PDD. DISCUSSION: Clinically significant rates of change in core clinical features can be detected and quantified in Lewy body dementia over a relatively short period (6 months) using common clinical instruments and thus may be useful as clinical endpoints for therapeutic trials of disease-modifying and symptomatic agents.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Matar E, White SR, Taylor JP, et al. Progression of Clinical Features in Lewy Body Dementia Can Be Detected Over 6 Months. Neurology. 2021. PMID: 34404743. doi:10.1212/WNL.0000000000012450

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。